BR112013027484A2 - composição farmacêutica ou nutracêutica com resistência gástrica com resistência contra a influência do etanol - Google Patents

composição farmacêutica ou nutracêutica com resistência gástrica com resistência contra a influência do etanol

Info

Publication number
BR112013027484A2
BR112013027484A2 BR112013027484A BR112013027484A BR112013027484A2 BR 112013027484 A2 BR112013027484 A2 BR 112013027484A2 BR 112013027484 A BR112013027484 A BR 112013027484A BR 112013027484 A BR112013027484 A BR 112013027484A BR 112013027484 A2 BR112013027484 A2 BR 112013027484A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical
ethanol
resistance
gastric
influence
Prior art date
Application number
BR112013027484A
Other languages
English (en)
Other versions
BR112013027484A8 (pt
Inventor
Christian Meier
Hedi Krachtus
Herbert Jung
Jan Hendrik Schattka
Jessica Del Rosario Ferrand
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of BR112013027484A2 publication Critical patent/BR112013027484A2/pt
Publication of BR112013027484A8 publication Critical patent/BR112013027484A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo patente de invenção: "composição farmacêutica ou nutracêutica com resistência gástrica com resistência contra a influência do etanol". a presente invenção refere-se uma composição farmacêutica ou nutracêutica com resistência gástrica, que compreende um núcleo, que compreende um ingrediente ativo farmacêutico ou nutracêutico ativo e uma camada de revestimento com resistência gástrica sobre o núcleo, em que a camada de revestimento com resistência gástrica compreende pelo menos 30% em peso do copolímero de (met)acrilato que compreende 10 a 40% em peso de ácido acrílico ou metacrílico, 10 a 80% em peso de um éster c4 a c8 alquila de ácido acrílico ou metacrílico e, opcionalmente, 0 a 60% em peso de outro monômero vinílico, através do que a liberação do ingrediente ativo farmacêutico ou nutracêutico não é maior do que 10% sob condições in vitro em ph 1,2 depois de 2 horas em meio de acordo com a usp com e sem a adição de etanol 20% (v/v).
BR112013027484A 2011-06-17 2012-06-12 Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato BR112013027484A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2011060098 2011-06-17
PCT/EP2012/061051 WO2012171884A1 (en) 2011-06-17 2012-06-12 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol

Publications (2)

Publication Number Publication Date
BR112013027484A2 true BR112013027484A2 (pt) 2017-01-10
BR112013027484A8 BR112013027484A8 (pt) 2022-07-05

Family

ID=46354217

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013027484A BR112013027484A8 (pt) 2011-06-17 2012-06-12 Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato

Country Status (13)

Country Link
US (1) US9775815B2 (pt)
JP (1) JP6099638B2 (pt)
KR (1) KR101902602B1 (pt)
CN (1) CN103501768B (pt)
AU (1) AU2012269187A1 (pt)
BR (1) BR112013027484A8 (pt)
CA (1) CA2839525C (pt)
ES (1) ES2600853T3 (pt)
HU (1) HUE030548T2 (pt)
IL (1) IL228396A0 (pt)
MX (1) MX356579B (pt)
RU (1) RU2649806C2 (pt)
WO (1) WO2012171884A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2839525C (en) 2011-06-17 2019-07-02 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
US10111838B2 (en) * 2014-11-26 2018-10-30 Evonik Roehm Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
JP2020533468A (ja) 2017-09-14 2020-11-19 エボニック オペレーションズ ゲーエムベーハー 持続放出特性およびエタノールの影響に対する耐性を示すポリマーおよび剤形
CN112469399A (zh) * 2018-03-09 2021-03-09 赢创运营有限公司 耐受乙醇影响的聚合物混合物
CN111989068A (zh) 2018-05-24 2020-11-24 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
MX2020012458A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
CN109232795A (zh) * 2018-09-21 2019-01-18 佛山市森昂生物科技有限公司 一种防水型高韧性包衣材料的制备方法
US20220087940A1 (en) * 2019-03-11 2022-03-24 Evonik Operations Gmbh Dosage form comprising a polymeric matrix
WO2020246463A1 (ja) * 2019-06-07 2020-12-10 日本曹達株式会社 微粒子用の湿式コーティング剤

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9414065U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE10220470A1 (de) * 2002-04-30 2003-11-20 Roehm Gmbh ph-sensitives Polymer
DE10011447A1 (de) 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
AU2001282617A1 (en) * 2000-10-16 2002-04-29 Hisamitsu Pharmaceutical Co. Inc. Compositions for external preparations
WO2003051340A1 (en) * 2001-12-19 2003-06-26 Astrazeneca Ab New film coating
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
JP3727290B2 (ja) * 2002-07-22 2005-12-14 日本カラコン株式会社 腸溶性水系コーティング剤
DE10250543A1 (de) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
US8168228B2 (en) * 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
AU2003292509B2 (en) * 2003-12-15 2007-08-02 Council Of Scientific And Industrial Research Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer
DE102004011349A1 (de) 2004-03-05 2005-09-22 Basf Ag Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
DE102006051020A1 (de) 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
CN100465201C (zh) * 2007-04-25 2009-03-04 上海大学 用作药物肠溶包衣材料的水溶性丙烯酸系树脂乳液的制备方法
KR101424653B1 (ko) * 2007-09-21 2014-08-06 에보니크 룀 게엠베하 에탄올의 영향에 대하여 내성을 가지는 ph-의존성 조절 방출 제약학적 오피오이드 조성물
SI2187875T1 (sl) * 2007-09-21 2012-12-31 Evonik Rohm Gmbh Od pH odvisen farmacevtski sestavek z nadzorovanim sproščanjem za ne-opioide z odpornostjo na vpliv etanola
KR101528957B1 (ko) 2008-09-24 2015-06-17 에보니크 룀 게엠베하 에탄올의 영향에 대하여 내성을 갖는 ph-의존성 조절 방출 제약학적 오피오이드 조성물
ES2537622T3 (es) 2008-09-24 2015-06-10 Evonik Röhm Gmbh Composición farmacéutica de liberación controlada dependiente del pH para compuestos no opioides con resistencia frente a la influencia del etanol
EP2408437A1 (en) 2009-03-18 2012-01-25 Evonik Röhm GmbH Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
PL2408436T3 (pl) 2009-03-18 2017-08-31 Evonik Röhm Gmbh Kompozycja farmaceutyczna o kontrolowanym uwalnianiu z odpornością na wpływ etanolu, wykorzystująca powłokę zawierającą neutralne polimery winylowe i zaróbki
CA2839525C (en) 2011-06-17 2019-07-02 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
PL2720681T3 (pl) * 2011-06-17 2017-05-31 Evonik Röhm Gmbh Kompozycja powlekająca odpowiednia do farmaceutycznych lub nutraceutycznych postaci dawkowania
BR112013032095A8 (pt) 2011-06-17 2022-07-05 Evonik Roehm Gmbh Composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas

Also Published As

Publication number Publication date
US9775815B2 (en) 2017-10-03
CN103501768A (zh) 2014-01-08
HUE030548T2 (en) 2017-05-29
CA2839525A1 (en) 2012-12-20
KR101902602B1 (ko) 2018-09-28
KR20140045942A (ko) 2014-04-17
BR112013027484A8 (pt) 2022-07-05
RU2649806C2 (ru) 2018-04-04
WO2012171884A1 (en) 2012-12-20
RU2014101230A (ru) 2015-07-27
CA2839525C (en) 2019-07-02
ES2600853T3 (es) 2017-02-13
MX356579B (es) 2018-06-05
AU2012269187A1 (en) 2013-09-26
JP6099638B2 (ja) 2017-03-22
US20140141092A1 (en) 2014-05-22
MX2013014142A (es) 2014-01-23
CN103501768B (zh) 2016-11-09
IL228396A0 (en) 2016-10-31
JP2014517020A (ja) 2014-07-17

Similar Documents

Publication Publication Date Title
BR112013027484A2 (pt) composição farmacêutica ou nutracêutica com resistência gástrica com resistência contra a influência do etanol
BR112013003581A2 (pt) formulação farmacêutica ou nutracêutica gastro resistente que compreende um ou mais sais do ácido algínico
BR112015021530A2 (pt) composição para cuidados pessoais, e, método para mitigar a perda de silicone depositado
BR112015025576A2 (pt) formulação para óleo de transmissão para redução do consumo de combustível
BR112014011527A2 (pt) composição de revestimento anti-incrustante, filme de revestimento anti-incrustante e substrato anti-incrustante, e método para produzir substrato anti-incrustante
MX2011009669A (es) Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante un revestimiento compuesto de una mezcla polimérica y excipientes.
BR112014013682B8 (pt) composição para cuidado pessoal
WO2007006353A3 (de) Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten
EP2492330A3 (en) Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet
BR112015014635A2 (pt) composição para cuidado pessoal, e, método para reduzir a perda de deposição de silicona de uma composição condicionadora detersiva em substratos queratinoso
BR112012008132A8 (pt) Composição em pó ou granulada, seu processo de preparação e seu uso
EP2135908A3 (en) Pressure-sensitive adhesive composition and pressure-sensitive adhesive sheet to be attached to metal surface
ATE547444T1 (de) Fluorpolymeremulsionen
BRPI0621996B8 (pt) preparação farmacêutica compreendendo um núcleo com um ingrediente ativo e com um ácido orgânico e/ou com o sal de um ácido orgânico, e um revestimento que envolve o núcleo e que compreende um ou mais copolímeros de (met)acrilato, e seu uso.
UA93530C2 (ru) Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения
BRPI0513743A (pt) medicamento em uma forma de multicamada
EP2324860A3 (en) Medical pressure-sensitive adhesive composition
MX2017006858A (es) Composición farmacéutica o nutracéutica con resistencia a la influencia del etanol.
WO2012084699A3 (en) Cosmetic composition comprising a cucurbic acid compound and an acrylic copolymer
ES2572277T3 (es) Composiciones fijadoras para el cabello
WO2009034431A3 (en) Controlled-release dosage forms for varenicline
MX2017015465A (es) Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol.
BR112017022097A2 (pt) composição fixadora de cabelos, e processo de fixação de cabelos
BR112013027486A2 (pt) combinação de um inibidor de fosfatidilinositol-3-cinase (pi3k) e um inibidor de mtor
BR112012008065A8 (pt) composição em pó ou granulada compreendendo um copolímero, um ácido dicarboxílico e um ácido monocarboxílico graxo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/16 , A61K 9/20

Ipc: A61K 47/32 (2006.01), A61K 9/28 (2006.01)

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: ROEHM GMBH (DE)

B25G Requested change of headquarter approved

Owner name: ROEHM GMBH (DE)

B25A Requested transfer of rights approved

Owner name: EVONIK DEGUSSA GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: EVONIK OPERATIONS GMBH (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2779 DE 09-04-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.